Stay updated on Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.

Latest updates to the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA 403 Forbidden page now appears when attempting to view the study record, blocking access to the study details. The previous content is replaced by the 403 message along with the site header and footer.SummaryDifference18%

- Check43 days agoChange DetectedThe page adds a funding note for 2018 (U.S. NIH Grant/Contract). The page revision has been updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page shows a revision label updated to v3.6.5, replacing the previous v3.6.4. This indicates a small software update rather than a change to the clinical study information.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of Revision: v3.6.3, indicating a minor update to the page's revision history.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page’s revision label was updated to v3.6.3, reflecting a minor update to the page’s metadata; the previous revision v3.6.2 is no longer listed.SummaryDifference0.0%

Stay in the know with updates to Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant in Patients With Nasal Polyposis and Asthma Clinical Trial page.